Skip to content

Ultrasound-guided transgluteal pudendal nerve block for postepisiotomy pain: a randomized, double-blind, placebo-controlled trial

Ultrasound-guided transgluteal pudendal nerve block for postepisiotomy pain: a randomized, double-blind, placebo-controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054003
Enrollment
Unknown
Registered
2021-12-06
Start date
2021-09-01
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postepisiotomy pain

Interventions

Experimental group VS control group:Ultrasound guided pudendal nerve block

Sponsors

The Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. 18-45-year-old women with vaginal delivery; 2. The obstetric inspection is approved by the competent doctor, and there is no special inspection abnormality; 3. Perform unilateral episiotomy for midwifery; 4. Require analgesia after lateral resection and sign the informed consent; 5. Assess ASA grades 1-2 before anesthesia.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to local anesthetics; 2. Delivery under general anesthesia; 3. Hemorrhoids or other perineal pain before pregnancy; 4. Factors considered by the anesthesiologist to cause difficulty in puncture or other post-puncture risks: obesity, severe coagulation dysfunction, infection of the puncture site, abnormal anatomy of the puncture approach, or other risks; 5. Perineal laceration during vaginal trial production; 6. The doctor or midwife in charge of the puerperium believes that the puerpera has concerns that the puerperium is not suitable to participate in the study, such as puerperal infection.

Design outcomes

Primary

MeasureTime frame
VAS pain score;

Countries

China

Contacts

Public ContactCao Lijun

The Second Xiangya Hospital, Central South University

hivit1103@csu.edu.cn+86 15974283099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026